|
 |
Manual of Lipid Disorders: Reducing the Risk for Coronary Heart Disease 3rd edition
Authors : Antonio M. Gotto, Henry J. Pownall
Language : ENGLISH
400p. 18.4x10.8 Paperback
Description
Lowering Plasma Cholesterol Reduces Total Mortality Rates ! Over the past several years tremendous advances have occurred in the understanding of atherothrombosis, plasma lipid metabolism and its relation to other metabolic factors, and how to reduce the risk for coronary heart disease (CHD). The goal of the book is to help physicians understand current CHD risk reduction findings and practice guidelines. Whilst it’s focus is still the control of dyslipidemia, the book also highlights perspectives regarding: SMOKING, HYPERTENSION, OBESITY, PHYSICAL INACTIVITY & DIABETES MELLITUS. and is also an important tool for reducing morbidity and mortality by diagnosis and treatment of lipid disorders. As well as containing the 2001 revised U.S. National Cholesterol Education Program (NCEP) guidelines for risk control in adults, (the first revision since 1993) MANUAL OF LIPID DISORDERS, 3RD EDITION, is a valuable and practical tool for understanding lipid disorders and reducing the risk for coronary heart disease.
Features:
- Brief reviews of the synthesis, assembly, and transport of lipoproteins.
- Current information about atherogenesis.
- Key clinical trial results.
Summary
Part 1: Fundamentals of Lipid Metabolism.
Plasma Lipoproteins: Structure, Nomenclature, and Occurrence. Intracellular Lipid Synthesis and Lipoprotein Assembly. Remodeling of Lipoproteins in the Plasma Compartment. Lipoprotein Catabolism and Its Regulation References.
Part 2: Artherosclerosis .
Atherosclerosis: Overview and Histologic Classification of Lesions. Evolution of Lesions. Lesion Regression and Stabilization References.
Part 3: Risk Control .
Observational Epidemiology and Risk Factors. Major Lipid-Regulating Drug Trials Assessing Clinical Events. National Cholestrol Education Program Clinicla Guidelines for Risk Control in Adults. Considerations in the Clinical Evaluation of Dyslipidemia.
Part 4: Therapeutic Interventions
.2. Dietary Modification. Other Lifestyle Changes and Major Modifiable Risk Factors. Lipid-Regulating Drugs and Low-Density Lipoprotein Apheresis References.
Part 5: Plasma Lipid Control and Coronary Heart Disease Risk Considerations in Population Subsets
.5. Women. The Elderly and Youths. U.S Ethnic Minorities. Adults with Diabetes Mellitus and Patients with Concomitant Dyslipidemia and Hypertension
References Index
Chart 1: Lipid Conversions, with NCEP Initial Clinical Action Limits in Adults
Chart 2: Cutpoints in Adult Clinical Practice Guidelines
Subject areas covered:
Medicine / Internal medicine
Medicine / Medical and surgical specialisations / Ardiology
|
Book Request form
Please fill out the form completely and click the Book Request button to request this invaluable book.
All fields are required.
|

|